LACRT
Extracellular glycoprotein lacritin
Also known as: LACRITIN, LACRT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZZ8
- Gene
- LACRT
- Ensembl
- ENSG00000135413
- Chromosome
- 12
- Canonical length
- 138 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
The protein encoded by this gene is highly expressed in the lacrimal glands and localized primarily to secretory granules and secretory fluid. It augments lacrimal acinar cell secretion, promotes ductal cell proliferation, and stimulates signaling through tyrosine phosphorylation and release of calcium. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
138 residues, UniProt reviewed canonical sequence.
>Q9GZZ8|LACRT
1 MKFTTLLFLA AVAGALVYAE DASSDSTGAD PAQEAGTSKP NEEISGPAEP ASPPETTTTA
61 QETSAAAVQG TAKVTSSRQE LNPLKSIVEK SILLTEQALA KAGKGMHGGV PGGKQFIENG
121 SEFAQKLLKK FSLLKPWALocalizationUniProt · AlphaFold · HPA
Whether an antibody against LACRT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 12 nTPM
- thymus: 0.7 nTPM
- breast: 0.5 nTPM
- skin: 0.5 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- salivary acinar cells: 169 nCPM
- lacrimal acinar cells: 159 nCPM
- neutrophils: 53 nCPM
- plasma cells: 15 nCPM
- salivary duct cells: 6.1 nCPM
- retinal pigment epithelial cells: 4.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 0.4 nTPM
- cerebral cortex: 0.3 nTPM
- amygdala: 0.2 nTPM
- basal ganglia: 0.2 nTPM
- pons: 0.2 nTPM
- cerebellum: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.74
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.37
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 1% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcineurin-NFAT signaling cascade
- calcium-mediated signaling
- defense response to bacterium
- epithelial structure maintenance
- negative regulation of apoptotic process
- negative regulation of lipopolysaccharide-mediated signaling pathway
- positive regulation of calcineurin-NFAT signaling cascade
- positive regulation of calcium-mediated signaling
- positive regulation of cell population proliferation
- positive regulation of epithelial cell proliferation
- positive regulation of epithelial cell proliferation involved in wound healing
- positive regulation of macroautophagy
- positive regulation of peptidyl-tyrosine phosphorylation
- positive regulation of release of sequestered calcium ion into cytosol
- positive regulation of secretion
- protein localization to Golgi apparatus
- tear secretion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LACRT as an antibody target. Whether an autoantibody or antibody against LACRT could matter depends on whether native LACRT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LACRT is annotated as secreted, so native LACRT circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LACRT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...